loadpatents
name:-0.006119966506958
name:-0.005763053894043
name:-0.0054390430450439
Bourne; Gregory Patent Filings

Bourne; Gregory

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bourne; Gregory.The latest application filed is for "peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases".

Company Profile
3.5.6
  • Bourne; Gregory - Jindalee AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
Grant 10,787,490 - Bhandari , et al. September 29, 2
2020-09-29
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases
App 20190300590 - BHANDARI; Ashok ;   et al.
2019-10-03
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
Grant 10,196,424 - Bourne , et al. Fe
2019-02-05
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
Grant 10,035,824 - Bhandari , et al. July 31, 2
2018-07-31
Hepcidin analogues and uses thereof
Grant 10,030,061 - Smythe , et al. July 24, 2
2018-07-24
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
Grant 10,023,614 - Bhandari , et al. July 17, 2
2018-07-17
Hepcidin Analogues And Uses Thereof
App 20180100004 - Smythe; Mark Leslie ;   et al.
2018-04-12
Hepcidin Analogues And Uses Thereof
App 20180086811 - Smythe; Mark Leslie ;   et al.
2018-03-29
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases
App 20180079782 - Bhandari; Ashok ;   et al.
2018-03-22
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases
App 20180079783 - Bhandari; Ashok ;   et al.
2018-03-22
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases
App 20180022778 - Bourne; Gregory ;   et al.
2018-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed